Sign in

NCT06531083Recruiting

Feasibility of Prospective Surveillance and Early Physical Therapy for Trismus

Feasibility of PRospective Surveillance and Early PhysiCal Therapy for TrIsmuS in Individuals With Head and Neck CancEr: A Single-Group Feasibility Trial (PRECISE)

Source: ClinicalTrials.gov · Last updated 12 Aug 2026

Brief summary (registry, in English)

Trismus, or restricted jaw movement, can occur in individuals with head and neck cancer (HNC) undergoing surgery or radiation therapy. There is a paucity of research examining interventions for trismus. We aim to assess the feasibility of prospective surveillance and early intervention to mitigate trismus in individuals undergoing HNC treatment. Method: The investigators will conduct a pilot single group feasibility study involving 30 individuals with HNC who will be undergoing radiation therapy. Participants will be identified at the HNC new patient clinic. Participants will be seen weekly during radiation therapy and will receive early intervention including manual therapy and a device-based jaw exercise regimen if presenting with 5% or greater reduction in jaw opening compared to pre-treatment. The investigators will assess recruitment and completion rates, intervention acceptability, and data collection procedures. Descriptive statistics will summarize feasibility metrics and participant demographics. Findings will inform the design of a larger multicentre trial.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
30 (estimated)
First submitted
23 Jul 2024
Start date
1 Mar 2025
Primary completion date
30 Sept 2026
Lead sponsor
University of Alberta
NCT number
NCT06531083

What you commit to

  • Study type: Interventional
  • Planned participants: 30
  • From 1 Mar 2025 to the primary completion date, 30 Sept 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous surgery for the temporomandibular joint that is not related to the HNC diagnosis.

Other illness

  • Local cancer recurrence or metastatic disease.

Other

  • Unable to provide informed consent.

Who the study is looking for

  • Have a diagnosis of oral, oropharyngeal, or nasopharyngeal cancer
  • Be scheduled to undergo cancer treatment that includes radiation therapy
  • Be able to read and understand English
  • Be an Alberta resident.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

SiteCityCountrySite status
University of Alberta - Cross Cancer Institute
Coordinator of this site? Confirm its status
EdmontonCanadaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.